134 related articles for article (PubMed ID: 31828541)
1. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models.
Elekonawo FMK; Bos DL; Goldenberg DM; Boerman OC; Rijpkema M
EJNMMI Res; 2019 Dec; 9(1):108. PubMed ID: 31828541
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
[No Abstract] [Full Text] [Related]
3. Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.
Derks YHW; Schilham MGM; Rijpkema M; Smeets EMM; Amatdjais-Groenen HIV; Kip A; van Lith SAM; van de Kamp J; Sedelaar JPM; Somford DM; Simons M; Laverman P; Gotthardt M; Löwik DWPM; Heskamp S; Lütje S
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2872-2884. PubMed ID: 37060367
[TBL] [Abstract][Full Text] [Related]
4. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis.
Dorst DN; Rijpkema M; Boss M; Walgreen B; Helsen MMA; Bos DL; Brom M; Klein C; Laverman P; van der Kraan PM; Gotthardt M; Koenders MI; Buitinga M
Rheumatology (Oxford); 2020 Dec; 59(12):3952-3960. PubMed ID: 32734285
[TBL] [Abstract][Full Text] [Related]
5. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
[TBL] [Abstract][Full Text] [Related]
6. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
[TBL] [Abstract][Full Text] [Related]
7. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
[TBL] [Abstract][Full Text] [Related]
8. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
[TBL] [Abstract][Full Text] [Related]
9. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
[TBL] [Abstract][Full Text] [Related]
10. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
Levin LV; Griffin TW
Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369
[TBL] [Abstract][Full Text] [Related]
11. Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate.
Tsai LC; Chen YL; Lee C; Chen HM; Chang ZN; Hung MW; Chao PL; Lin JY
Dis Colon Rectum; 1995 Oct; 38(10):1067-74. PubMed ID: 7555421
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
Guadagni F; Tortora G; Roselli M; Clair T; Cho-Chung YS; Schlom J; Greiner JW
Int J Cancer; 1991 May; 48(3):413-22. PubMed ID: 1645700
[TBL] [Abstract][Full Text] [Related]
13. Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy.
Tamaoki M; Yokoyama A; Horimatsu T; Hirohashi K; Amanuma Y; Higuchi H; Mitani Y; Yoshioka M; Ohashi S; Muto M
Esophagus; 2021 Oct; 18(4):817-824. PubMed ID: 34106353
[TBL] [Abstract][Full Text] [Related]
14. CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production.
Tibbetts LM; Doremus CM; Tzanakakis GN; Vezeridis MP
Cancer; 1993 Jan; 71(2):315-21. PubMed ID: 8422623
[TBL] [Abstract][Full Text] [Related]
16. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
[TBL] [Abstract][Full Text] [Related]
17. Transcriptionally targeted in vivo gene therapy for carcinoembrionic antigen-producing adenocarcinoma.
Konishi F; Maeda H; Yamanishi Y; Hiyama K; Ishioka S; Yamakido M
Hiroshima J Med Sci; 1999 Sep; 48(3):79-89. PubMed ID: 10598410
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
19. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Karacay H; McBride WJ; Griffiths GL; Sharkey RM; Barbet J; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2000; 11(6):842-54. PubMed ID: 11087333
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
